← All trials
NCT04368377
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 6, 2020
- Primary completion
- Apr 23, 2020
- Completion date
- Apr 23, 2020
- First posted
- Apr 29, 2020
- Last posted
- Apr 29, 2020
- Enrollment
- 5
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of MilanLead sponsor
- University of MilanReponsible party - principal investigator
- Fondazione "Un Cuore per Milano" - a no profit foundationCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.